Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Kalhs

Showing results (11-20 of 60) with videos related to

Pageof 6
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 29, 2007
A single-center pilot validation study of a new chronic GVHD skin scoring systemHildegard T Greinix, David Pohlreich, Jacqueline Maalouf, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|June 16, 2007
ABO-incompatible allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning: close association with transplant-associated microangiopathyNina Worel, Hildegard T Greinix, Gerda Leitner, et al.
Transfusion|February 16, 2018
Extracorporeal photopheresis as second-line therapy for patients with acute graft-versus-host disease: does the number of cells treated matter?Nina Worel, Elisabeth Lehner, Harald Führer, et al.
Clinical Immunology (Orlando, Fla.)|September 10, 2002
Effects of extracorporeal photoimmunotherapy on soluble IL-2Ralpha, TNF-RI, and CD8 in patients with steroid-resistant acute graft-versus-host diseaseAlexandra Kokalj, Hildegard T Greinix, Marina Ciovica, et al.
Wiener Klinische Wochenschrift|February 28, 2016
Complete neurologic and cognitive recovery after plasmapheresis in a patient with chronic inflammatory demyelinating polyneuropathy after allogeneic hematopoietic stem cell transplantationUrsula Vogl, Gerda Leitner, Assunta Dal-Bianco, et al.
Frontiers in Medicine|February 15, 2021
A Prospective Controlled Trial to Evaluate Safety and Efficacy of <i>in vitro</i> Expanded Recipient Regulatory T Cell Therapy and Tocilizumab Together With Donor Bone Marrow Infusion in HLA-Mismatched Living Donor Kidney Transplant Recipients (Trex001)Rainer Oberbauer, Matthias Edinger, Gabriela Berlakovich, et al.
Transfusion|January 22, 2005
The influence of human platelet antigen match on the success of allogeneic peripheral blood progenitor cell transplantation following a reduced-intensity conditioning regimenGerda C Leitner, Gabriele Stiegler, Peter Kalhs, et al.
American Journal of Infection Control|June 28, 2011
Effectiveness of preventive measures for hemato-oncologic patients undergoing stem cell transplantation during a period of hospital constructionJutta Berger, Birgit Willinger, Magda Diab-Elschahawi, et al.
Transfusion|November 9, 2002
Severe immune hemolysis after minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioningNina Worel, Hildegard T Greinix, Felix Keil, et al.
Transfusion|December 2, 2011
Frequency and prognostic value of D alloantibodies after D-mismatched allogeneic hematopoietic stem cell transplantation after reduced-intensity conditioningNina Worel, Alexandra Böhm, Werner Rabitsch, et al.
Pageof 6

Showing results (11-20 of 60) with videos related to

Sort By:
Pageof 6
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 29, 2007
A single-center pilot validation study of a new chronic GVHD skin scoring systemHildegard T Greinix, David Pohlreich, Jacqueline Maalouf, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|June 16, 2007
ABO-incompatible allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning: close association with transplant-associated microangiopathyNina Worel, Hildegard T Greinix, Gerda Leitner, et al.
Transfusion|February 16, 2018
Extracorporeal photopheresis as second-line therapy for patients with acute graft-versus-host disease: does the number of cells treated matter?Nina Worel, Elisabeth Lehner, Harald Führer, et al.
Clinical Immunology (Orlando, Fla.)|September 10, 2002
Effects of extracorporeal photoimmunotherapy on soluble IL-2Ralpha, TNF-RI, and CD8 in patients with steroid-resistant acute graft-versus-host diseaseAlexandra Kokalj, Hildegard T Greinix, Marina Ciovica, et al.
Wiener Klinische Wochenschrift|February 28, 2016
Complete neurologic and cognitive recovery after plasmapheresis in a patient with chronic inflammatory demyelinating polyneuropathy after allogeneic hematopoietic stem cell transplantationUrsula Vogl, Gerda Leitner, Assunta Dal-Bianco, et al.
Frontiers in Medicine|February 15, 2021
A Prospective Controlled Trial to Evaluate Safety and Efficacy of <i>in vitro</i> Expanded Recipient Regulatory T Cell Therapy and Tocilizumab Together With Donor Bone Marrow Infusion in HLA-Mismatched Living Donor Kidney Transplant Recipients (Trex001)Rainer Oberbauer, Matthias Edinger, Gabriela Berlakovich, et al.
Transfusion|January 22, 2005
The influence of human platelet antigen match on the success of allogeneic peripheral blood progenitor cell transplantation following a reduced-intensity conditioning regimenGerda C Leitner, Gabriele Stiegler, Peter Kalhs, et al.
American Journal of Infection Control|June 28, 2011
Effectiveness of preventive measures for hemato-oncologic patients undergoing stem cell transplantation during a period of hospital constructionJutta Berger, Birgit Willinger, Magda Diab-Elschahawi, et al.
Transfusion|November 9, 2002
Severe immune hemolysis after minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioningNina Worel, Hildegard T Greinix, Felix Keil, et al.
Transfusion|December 2, 2011
Frequency and prognostic value of D alloantibodies after D-mismatched allogeneic hematopoietic stem cell transplantation after reduced-intensity conditioningNina Worel, Alexandra Böhm, Werner Rabitsch, et al.
Pageof 6